Manganese-induced neurodegenerative diseases and possible therapeutic approaches. (1st November 2020)

• Record Type: Journal Article
• Authors: Martins, Airton C.; Gubert, Priscila; Villas Boas, Gustavo R.; Meirelles Paes, Marina; Santamaría, Abel; Lee, Eunsook; Tinkov, Alexey A.; Bowman, Aaron B.; Aschner, Michael
• Is Part Of: Expert review of neurotherapeutics. Volume 20:Number 11(2020)
• Page Start: 1109
• Page End: 1121
• Publication Date: 2020-11-01
• Subjects: Alzheimer's disease -- Huntington's disease -- Parkinson's disease -- amyotrophic lateral sclerosis -- manganese -- heavy metals; Neuropharmacology -- Periodicals; 615.7805
• DOI: 10.1080/14737175.2020.1807330
• Languages: English
• ISSNs: 1473-7175

Abstract

ABSTRACT: Introduction: Neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis and prion disease represent important public health concerns. Exposure to high levels of heavy metals such as manganese (Mn) may contribute to their development. Areas covered: In this critical review, we address the role of Mn in the etiology of neurodegenerative diseases and discuss emerging treatments of Mn overload, such as chelation therapy. In addition, we discuss natural and synthetic compounds under development as prospective therapeutics. Moreover, bioinformatic approaches to identify new potential targets and therapeutic substances to reverse the neurodegenerative diseases are discussed. Expert opinion: Here, the authors highlight the importance of better understanding the molecular mechanisms of toxicity associated with neurodegenerative diseases, and the role of Mn in these diseases. Additional emphasis should be directed to the discovery of new agents to treat Mn-induced diseases, since present day chelator therapies have limited bioavailability. Furthermore, the authors encourage the scientific community to develop research using libraries of compounds to screen those compounds that show efficacy in regulating brain Mn levels. In addition, bioinformatics may provide novel insight for pathways and clinical treatments associated with Mn-induced neurodegeneration, leading to a new direction in Mn toxicological research.